Correlation study between interleukin-6 levels and coronary reflow

被引:1
作者
Guo, F. -M. [1 ]
Han, X. -H. [2 ]
Guo, Y. -Y. [3 ]
Zhang, D. -M. [1 ]
Tang, F. -J. [4 ]
Zhao, L. [1 ]
Ji, L. -L. [1 ]
Liu, W. -B. [1 ]
机构
[1] Yantaishan Hosp Yantai, Dept Cardiol, Yantai, Peoples R China
[2] Qingdao Univ, Med Coll, Dept Physiol, Qingdao, Peoples R China
[3] Jilin Univ, Sch Publ Hlth, Changchun, Jilin, Peoples R China
[4] Ocean Univ China, Dept Lib, Qingdao, Peoples R China
关键词
IR model; Interleukin-6; Coronary reflow; Reperfusion; TIMI frame count; C-REACTIVE PROTEIN; TIMI FRAME COUNT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To analyze the correlation between local interleukin-6 (IL-6) levels in different parts of blood vessel and the record of Thrombolysis in Myocardial Infarction (TIMI) frame count (TFC) after myocardial ischemia-reperfusion (IR) model. MATERIALS AND METHODS: Establishment of IR model in Yorkshire pigs, the pigs were divided into two groups (n=6). Experiment group pigs were administrated with Shenfu injection (SF) intravenously (1 mL/kg), control group was given saline injection. The blood reflowed after 30 min. TIMI was recorded to evaluate the coronary blood flow and myocardial perfusion. IL-6 levels in venous sheath, coronary sinus, artery sinus, and proximal coronary artery were determined by ELISA. RESULTS: The records of TIMI in experimental group were higher than that in control group. The difference was statistically significant (p < 0.05). The level of IL-6 increased obviously compared with control group after reperfusion (p < 0.05). Shenfu injection reduced the level of IL-6. IL-6 level at the coronary sinus was positively correlated with TIMI in experimental group (p = 0.03, R-2 = 0.97) but not in control group. CONCLUSIONS: IL-6 levels were significantly increased after reperfusion, which aggravated myocardial injury. IL-6 may be associated with coronary reflow, but further study is needed.
引用
收藏
页码:1837 / 1842
页数:6
相关论文
共 50 条
  • [31] Correlation of interleukin-6 with Epstein-Barr virus levels in COVID-19
    Lehner, Georg Franz
    Klein, Sebastian Johann
    Zoller, Heinz
    Peer, Andreas
    Bellmann, Romuald
    Joannidis, Michael
    CRITICAL CARE, 2020, 24 (01)
  • [32] OUTCOME FROM SEVERE TRAUMATIC BRAIN INJURY - CORRELATION WITH CSF INTERLEUKIN-6 LEVELS
    MEDARY, MB
    KO, K
    HARIRI, RJ
    GHAJAR, J
    JOURNAL OF NEUROSURGERY, 1995, 82 (02) : A374 - A375
  • [33] The Relationship between Interleukin-6 Promotor Polymorphisms and Slow Coronary Flow Phenomenon
    Liu, Chun-Ling
    Xue, Zong-Qian
    Gao, Shu-Ping
    Chen, Chu
    Chen, Xiao-Hu
    Pan, Min
    Wang, Zhen-Xing
    CLINICAL LABORATORY, 2016, 62 (05) : 947 - 953
  • [34] Interleukin-6 and melanoma
    Hoejberg, Lise
    Bastholt, Lars
    Schmidt, Henrik
    MELANOMA RESEARCH, 2012, 22 (05) : 327 - 333
  • [35] SERUM INTERLEUKIN-6 LEVELS IN PATIENTS WITH THROMBOCYTOSIS
    HOLLEN, CW
    HENTHORN, J
    KOZIOL, JA
    BURSTEIN, SA
    LEUKEMIA & LYMPHOMA, 1992, 8 (03) : 235 - 241
  • [36] Raised interleukin-6 levels in obese patients
    Roytblat, L
    Rachinsky, M
    Fisher, A
    Greemberg, L
    Shapira, Y
    Doudevani, A
    Gelman, S
    OBESITY RESEARCH, 2000, 8 (09): : 673 - 675
  • [37] Modification of the Interleukin-6 Response to Air Pollution by Interleukin-6 and Fibrinogen Polymorphisms
    Ljungman, Petter
    Bellander, Tom
    Schneider, Alexandra
    Breitner, Susanne
    Forastiere, Francesco
    Hampel, Regina
    Illig, Thomas
    Jacquemin, Benedicte
    Katsouyanni, Klea
    von Klot, Stephanie
    Koenig, Wolfgang
    Lanki, Timo
    Nyberg, Fredrik
    Pekkanen, Juha
    Pistelli, Riccardo
    Pitsavos, Christos
    Rosenqvist, Marten
    Sunyer, Jordi
    Peters, Annette
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2009, 117 (09) : 1373 - 1379
  • [38] Association between local interleukin-6 levels and slow flow/microvascular dysfunction
    Fangming Guo
    Mei Dong
    Faxin Ren
    Chuanhuan Zhang
    Jianping Li
    Zhigang Tao
    Jun Yang
    Guangping Li
    Journal of Thrombosis and Thrombolysis, 2014, 37 : 475 - 482
  • [39] Role of interleukin-6 gene polymorphisms in the risk of coronary artery disease
    Wang, K.
    Dong, P. S.
    Zhang, H. F.
    Li, Z. J.
    Yang, X. M.
    Liu, H.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 3177 - 3183
  • [40] Interleukin-6 promotor polymorphisms and coronary vasospastic angina in Han Chinese
    Wang, Ying
    Li, Gang
    Su, Ya-Min
    Pan, Hai-Yan
    Geng, Hai-Hua
    Fan, Meng-Kan
    Pan, Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (09): : 2858 - 2864